Aryl sulfonic pyridoxines as antiplatelet agents
    7.
    发明授权
    Aryl sulfonic pyridoxines as antiplatelet agents 失效
    芳基磺酰吡哆醇作为抗血小板药

    公开(公告)号:US07459468B2

    公开(公告)日:2008-12-02

    申请号:US10974707

    申请日:2004-10-28

    CPC分类号: C07D213/66 C07D491/04

    摘要: Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.

    摘要翻译: 描述了具有用于治疗心血管和心血管相关疾病的抗血小板聚集特性的芳基磺酰吡哆醇化合物。 所述方法涉及给予包含芳基磺酸吡哆醇的药物组合物。

    Aryl sulfonic pyridoxines as antiplatelet agents
    8.
    发明申请
    Aryl sulfonic pyridoxines as antiplatelet agents 失效
    芳基磺酰吡哆醇作为抗血小板药

    公开(公告)号:US20060094748A1

    公开(公告)日:2006-05-04

    申请号:US10974707

    申请日:2004-10-28

    CPC分类号: C07D213/66 C07D491/04

    摘要: Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.

    摘要翻译: 描述了具有用于治疗心血管和心血管相关疾病的抗血小板聚集特性的芳基磺酰吡哆醇化合物。 所述方法涉及给予包含芳基磺酸吡哆醇的药物组合物。

    Treatment of cardiovascular and related pathologies
    10.
    发明授权
    Treatment of cardiovascular and related pathologies 失效
    治疗心血管及相关病理

    公开(公告)号:US07148233B2

    公开(公告)日:2006-12-12

    申请号:US10639948

    申请日:2003-08-12

    IPC分类号: A61K31/44 A61K31/535

    摘要: Methods for treating cardiovascular and related diseases such as hypertrophy are described. The methods are directed to concurrently administering a compound such as pyridoxal-5′-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

    摘要翻译: 描述了治疗心血管和相关疾病如肥大的方法。 该方法涉及与治疗性心血管化合物同时施用化合物如吡哆醛-5'-磷酸,吡哆胺,吡哆醛或3-酰化吡哆醛类似物。